Colorectal Cancer: New Perspectives

AsmaH. Qudayr¹, Ahmed M. Kabel^{1, 2,} , Maaly A. AbdElmaaboud², Waleed Y. Alghamdi³ and AmalA. Alghorabi³

¹Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia

²Pharmacology Department, Faculty of Medicine, Tanta University, Tanta, Egypt

³Pharm D, College of Pharmacy, Taif University, Taif, Saudi Arabia

Cite this paper:
AsmaH. Qudayr, Ahmed M. Kabel, Maaly A. AbdElmaaboud, Waleed Y. Alghamdi and AmalA. Alghorabi. Colorectal Cancer: New Perspectives. Journal of Cancer Research and Treatment. 2018; 6(3):80-83. doi: 10.12691/jcrt-6-3-4

Abstract

Colorectal cancer is one of the gastrointestinal malignant tumors that carries relatively poor prognosis. It represents one of the most common cancers in males and the third commonest cancer among females worldwide. Various factors may contribute to the pathogenesis of colorectal cancer such as adenomatous polyps and personal history of chronic inflammatory bowel disease. Early colorectal carcinoma is usually asymptomatic. Bleeding from the rectum is the most common presenting symptom. Intestinal obstruction and distant metastasis are life threatening complications of colorectal carcinoma. Accurate diagnosis is achieved by sampling of areas of the colon suspicious for possible tumor development during colonoscopy or sigmoidoscopy. Lines of treatment include surgery, chemotherapy, radiotherapy and biologic treatment. This review sheds light on colorectal carcinoma regarding its prevalence, etiology, clinical presentation, diagnosis and possible lines of management.

Keywords:
colorectal cancer perspectives etiology diagnosis management

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Marley AR, Nan H. Epidemiology of colorectal cancer. International Journal of Molecular Epidemiology and Genetics 2016; 7(3): 105-14.
[2]	Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014; 64(2):104-17.
[3]	Fazeli MS, Keramati MR. Rectal cancer: a review. Medical Journal of the Islamic Republic of Iran 2015; 29: 171.
[4]	Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65:87.
[5]	Ryerson AB, Eheman CR, Altekruse SF, et al. Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer 2016; 122: 1312.
[6]	Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66:7.
[7]	Vega P, Valentín F, Cubiella J. Colorectal cancer diagnosis: Pitfalls and opportunities. World Journal of Gastrointestinal Oncology. 2015; 7(12): 422-433.
[8]	Simon K. Colorectal cancer development and advances in screening. Clinical Interventions in Aging. 2016; 11: 967-76.
[9]	Rath-Wolfson L, Purim O, Ram E, Morgenstern SKoren R, Brenner B. Expression of estrogen receptor ß1 in colorectal cancer: Correlation with clinicopathological variables. Oncol Rep 2012; 27(6): 2017-22.
[10]	Alsanea N, Abduljabbar AS, Alhomoud S, Ashari LH, Hibbert D, Bazarbashi S.Colorectal cancer in Saudi Arabia: incidence, survival, demographics and implications for national policies. Ann Saudi Med 2015; 35(3):196-202.
[11]	Zubaidi AM, AlSubaie NM, AlHumaid AA, Shaik SA, AlKhayal KA, AlObeed OA. Public Awareness of Colorectal Cancer in Saudi Arabia: A Survey of 1070 Participants in Riyadh. Saudi Journal of Gastroenterology 2015;21(2):78-83.
[12]	Li J, Yi C-H, Hu Y-T, et al. TNM Staging of Colorectal Cancer Should be Reconsidered According to Weighting of the T Stage: Verification Based on a 25-Year Follow-Up. Silva Vaz. P, ed. Medicine. 2016;95(6):e2711.
[13]	Dukes CE. The classification of cancer of the rectum. Journal of Pathological Bacteriology 1932;35:323
[14]	Astler VB, Coller FA: The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg1954; 139:846.
[15]	Jawad N, Direkze, N, Leedham, SJ.Inflammatory bowel disease and colon cancer". Recent Results in Cancer Research. Recent Results in Cancer Research 2011; 185: 99-115.
[16]	Nordlinger B, Starling N. Colorectal cancer. Lancet 2010; 375 (9719): 1030-47.
[17]	Juhn E, Khachemoune, A. Gardner syndrome: skin manifestations, differential diagnosis and management. American Journal of Clinical Dermatology2010; 11(2):117-22.
[18]	Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastroenterol 2010; 138: 2044-58.
[19]	Chan AT, Giovannucci EL. Primary Prevention of Colorectal Cancer. Gastroenterol 2010; 138(6): 2029-43.
[20]	Song M, Garrett WS, Chan AT. Nutrients, Foods, and Colorectal Cancer Prevention. Gastroenterol 2015; 148(6): 1244-60.
[21]	Adelstein BA, Macaskill, P, Chan, SF, Katelaris, PH, Irwig, L. Most bowel cancer symptoms do not indicate colorectal cancer and polyps.BMC Gastroenterol 2011; 11:65.
[22]	Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous Polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American Col¬lege of Radiology. CA Cancer J Clin 2008; 58: 130-60.
[23]	Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, Starling N. Colorectal cancer. Lancet 2010; 375 (9719): 1030-47.
[24]	Zhang Y, Chen Z, Li J. The current status of treatment for colorectal cancer in China: A systematic review. Boros. LG, ed. Medicine 2017; 96(40):e8242.
[25]	Moghimi-Dehkordi B, Safaee A. An overview of colorectal cancer survival rates and prognosis in Asia. World Journal of Gastrointestinal Oncology 2012; 4(4): 71-5.
[26]	Kabel AM, AbdElmaaboud MA (2014). Cancer: Role of Nutrition, Pathogenesis, Diagnosis and Management. World Journal of Nutrition and Health; 2(4): 48-51.